CYP1B1 activated the PKC signaling pathway by degrading ACSL4, increased the expression of FBXO10, and promoted the ubiquitination and degradation of ACSL4, thereby making tumor cells resistant to ferroptosis. This evidence concerns the gene ACSL4 and neoplasm.